CLS Americas and URN Announce First Patient Treated in Clinical Study “Targeted MRI/ US Fusion Transperineal Laser Ablation of Low-to-Intermediate Risk Prostate Cancer”
April 20, 2022 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif. and MIAMI, April 20, 2022 (GLOBE NEWSWIRE) -- CLS Americas, a subsidiary of Clinical Laserthermia Systems AB, today announced the first patient has been safely treated in its recently...
CLS Targets MRI-US Fusion-Guided Focal Laser Ablation of Prostate Tumors
October 25, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 25, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation (FLA) systems, today announced that a...
CLS Exhibits MRI-Guided, Focal Laser Ablation System for Prostate Cancer at the 94th National Congress of the Italian Society of Urology
October 15, 2021 04:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
RICCIONE, Italy, Oct. 15, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS) today announced it will present its high precision, image-guided TRANBERG® Laser Thermal Therapy...
Scientific Article Covering Immune Modulating Interstitial Laser Thermotherapy by CLS’ Co-founder Professor Karl-Göran Tranberg Published in the Journal “Frontiers in Oncology”
July 19, 2021 02:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 19, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that a review...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
July 07, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS and University Hospital Magdeburg Begin Study of MRI-Ultrasound, Fusion-Guided Focal Laser Ablation Treatments of Prostate Cancer
July 07, 2021 07:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, July 07, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), developer of high precision, image-guided focal laser ablation systems, today announced that its...
CLS Strengthens its Organization with New Employees in Key Positions for Continued Global Establishment
January 13, 2021 03:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Jan. 13, 2021 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), a developer of advanced innovative products for high-precision, image-guided laser ablation, today...
CLS Receives New CPT® Reimbursement Code Approval by American Medical Association for Ultrasound-Guided Focal Laser Ablation of Prostate Cancer
November 04, 2020 05:00 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Nov. 04, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems AB (publ) (CLS), today announced the American Medical Association (AMA) has approved its application and issued a...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
October 12, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
IRVINE, Calif., Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...
CLS and University Hospital Magdeburg launch clinical trial regarding focal laser ablation treatment of localized prostate cancer
October 12, 2020 02:30 ET
|
Clinical Laserthermia Systems Americas, Inc.
LUND, Sweden, Oct. 12, 2020 (GLOBE NEWSWIRE) -- Clinical Laserthermia Systems (publ) and Otto-von-Guericke-University Magdeburg, Medical faculty are entering into an agreement regarding an...